{"abstract": "Novartis is in talks to buy parts of its Irish peer Elan, including its multiple sclerosis products and its Alzheimer\u2019s disease drug pipeline, The Sunday Times reported.", "web_url": "https://dealbook.nytimes.com/2009/06/29/novartis-in-talks-for-parts-of-elan-report-says/", "snippet": "Novartis is in talks to buy parts of its Irish peer Elan, including its multiple sclerosis products and its Alzheimer\u2019s disease drug pipeline, The Sunday Times reported.", "lead_paragraph": "Swiss drugmaker Novartis is in talks to buy parts of Irish peer Elan, including its flagship multiple sclerosis products and its Alzheimer\u2019s disease pipeline, The Sunday Times reported.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Novartis in Talks for Parts of Elan, Report Says", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2009-06-29T10:24:17+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/4bfea8aa-2aba-58a8-8b8e-5639f3011ac9", "word_count": 189, "uri": "nyt://article/4bfea8aa-2aba-58a8-8b8e-5639f3011ac9"}